February 23, 2026
1 min read

CDMO Bora locks in 5-year, $250M production agreement with GSK

With a productive working relationship between the two companies already well established, Bora Pharmaceuticals is renewing a $250 million global manufacturing agreement with British drugmaker GSK.

Leave a Reply

Your email address will not be published.

Previous Story

Results Outweigh Side Effects Among Ozempic/Wegovy Users, Study Says MedNews

Next Story

IMCD to acquire Willows Ingredients to expand food & nutrition presence in UK and Ireland

Previous Story

Results Outweigh Side Effects Among Ozempic/Wegovy Users, Study Says MedNews

Next Story

IMCD to acquire Willows Ingredients to expand food & nutrition presence in UK and Ireland

Latest from Blog

ROFI Drives New Approach to Crop Nutrition

With input costs continuing to pressure farm budgets, some growers are making difficult decisions to reduce fertilizer application rates. While that strategy may ease upfront expenses, it is also accelerating a broader
Go toTop